UPDATE - Canaccord Genuity Upgraded Omeros Corp. (OMER) to Buy; Impressive Efficacy Data From First OMS302 Phase 3 Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/23/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. AVGO
7. SPCX
8. BABA
9. BJ
10. NTES

Go back to UPDATE - Canaccord Genuity Upgraded Omeros Corp. (OMER) to Buy; Impressive Efficacy Data From First OMS302 Phase 3 Trial
Omeros Corporation (NASDAQ: OMER) Delayed: 19.27 +0.64 (3.44%)
Previous Close $18.63    52 Week High $16.80 
Open $18.64    52 Week Low $7.20 
Day High $19.58    P/E N/A 
Day Low $18.41    EPS $-1.64 
Volume 2,582,610